ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-OR081

Role of COUP-TFII in Pericyte Activation and Kidney Fibrosis

Session Information

Category: Acute Kidney Injury

  • 001 AKI: Basic

Authors

  • Li, Li, Brigham & Women's Hospital/Harvard Medical School, Boston, Massachusetts, United States
  • Xiao, Xiaoyan, Brigham & Women's Hospital/Harvard Medical School, Boston, Massachusetts, United States
  • Ichimura, Takaharu, Brigham & Women's Hospital/Harvard Medical School, Boston, Massachusetts, United States
  • Wilflingseder, Julia, Brigham & Women's Hospital/Harvard Medical School, Boston, Massachusetts, United States
  • Bonventre, Joseph V., Brigham & Women's Hospital/Harvard Medical School, Boston, Massachusetts, United States
Background

Genetic fate mapping studies suggest that pericytes are the main source of myofibroblasts enriched in injury-induce kidney fibrosis. The transcriptional network that controls the pericyte-myofibroblast transdifferentiation is poorly understood. Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII) is a transcription factor critical to the kidney development. It is broadly detected in the mesenchyme of developing organs and has a profound impact on organogenesis and cell fate determination.

Methods

We measured COUP-TFII mRNA by quantitative real-time PCR (qRT-PCR) and protein by Western Blot from normal C57BL/6 mouse kidneys and at different times after unilateral ureter obstruction (UUO). To assess the origin of COUP-TFII+ cells, we crossed Forkhead Box D1 (Foxd1)-Cre driver mice to tdTomato reporter mice to genetically label the Foxd1-derived stromal cells. In vitro, knockdown of COUP-TFII was attained by transfecting a small interfering RNA (siRNA) into CH310T1/2 (pericyte-like cells). COUP-TFII and αSMA expression was evaluated in tissue by immunostaining and in siRNA-transfected CH310T1/2 by RT-PCR.

Results

In non-injured kidney, expression of COUP-TFII is sparsely distributed in interstitial cells, Bowman’s capsule and to a lesser extent in tubules. Cells expressing COUP-TFII are PDGFRβ+ (pericytes/fibroblasts) and are adjacent to CD31+ (endothelial) cells. Most COUP-TFII+ cells are localized in the region of Foxd1-derived stromal cells. Upon injury, COUP-TFII expression is significantly increased in αSMA+ cells (myofibroblasts) localized within the fibrotic region. COUP-TFII expression did not overlap with F4/80 (macrophages) staining. Both mRNA and protein levels of COUP-TFII increased at 5, 7 and 10 days after UUO and are associated with increased levels of αSMA at the same time point. In vitro, knockdown of COUP-TFII by siRNA results in decreased αSMA expression in pericyte-like cells.

Conclusion

COUP-TFII is expressed at basal levels in non-injured kidney in Foxd1-derived stromal cells. Upon injury, COUP-TFII expression increased in αSMA+ cells localized within the fibrotic region. Attenuation of COUP-TFII expression is associated with reduced expression of αSMA in pericyte-like cells. These data suggest that COUP-TFII may play a role in the regulation of pericyte-myofibroblast transdifferentiation in injury-induce kidney fibrosis.

Funding

  • Other NIH Support